Sertraline - Adverse effects
Research News and Information

Monday, November 23, 2009

Sertraline-induced rhabdomyolysis in an elderly patient with dementia and comorbidities.

28 Jun 2009 OBJECTIVE: To describe a case of sertraline-induced rhabdomyolysis in an elderly patient with dementia and comorbidities. CASE SUMMARY: A 71-year-old woman visited a psychiatrist in September 2007 for her depressed mood. Her medical history included ... Read more...

Depression and cognitive complaints following mild traumatic brain injury.

30 May 2009 Traumatic brain injury (TBI) is a common occurrence with multiple possible neuropsychiatric sequelae, including problems with cognition, emotion, and behavior. While many individuals experience significant improvement over the first months following ... Read more...

A pooled analysis of suicidality in double-blind, placebo-controlled studies of sertraline in adults.

29 Apr 2009 OBJECTIVE: The analyses were conducted to identify possibly suicide-related adverse events in Pfizer-sponsored, phases 2 through 4, placebo-controlled, completed studies of sertraline in adult patients and evaluate the risk of suicidality with ... Read more...

Latest indexed articles for 'Sertraline - Adverse effects'

These are the very latest articles for this heading:

• Sertraline-induced rhabdomyolysis in an elderly patient with dementia and comorbidities. 28 Jun 2009
• Use of SSRIs in pregnancy: neonatal implications. 30 May 2009
• Putative neuroleptic malignant syndrome associated with sertraline withdrawal. 30 May 2009
• Depression and cognitive complaints following mild traumatic brain injury. 30 May 2009
• A pooled analysis of suicidality in double-blind, placebo-controlled studies of sertraline in adults. 29 Apr 2009
• Time to relapse after short- or long-term treatment of severe premenstrual syndrome with sertraline. 29 Apr 2009
• Sertraline versus other antidepressive agents for depression. 13 Apr 2009
• Sexual function in postpartum women treated for depression: results from a randomized trial of nortriptyline versus sertraline. 8 Mar 2009
• An imperfect literature and evidence-based medicine. 27 Feb 2009
• Sertraline-induced photoallergic reaction. 30 Jan 2009
• Early adversity in chronic depression: clinical correlates and response to pharmacotherapy. 30 Dec 2008
• Neopterin and C-reactive protein in the course of Stevens-Johnson syndrome: report of a case. 30 Dec 2008
• Effects of SNS activation on SSRI-induced sexual side effects differ by SSRI. 30 Dec 2008
• Pain and palliative care pharmacotherapy literature summaries and analyses. 30 Dec 2008
• Successful medication withdrawal after cognitive-behavioral therapy in a treatment-resistant preadolescent male with obsessive-compulsive disorder. 30 Dec 2008
• Hyperpigmentation with amisulpride. 30 Dec 2008
• Treatment that works for anxious children. 30 Dec 2008
• Violent parasomnia associated with a selective serotonin reuptake inhibitor: a case report. 29 Nov 2008
• Drug-induced lupus secondary to sertraline. 29 Nov 2008
• Nonverbal communication sets the conditions for the relationship between parental bonding and the short-term treatment response in depression. 27 Nov 2008

See a longer list of these articles.

Technical information about 'Sertraline'

Definition: A selective serotonin uptake inhibitor that is used in the treatment of depression.

Chemical name: 1-Naphthalenamine,1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-, (1S-cis)-

Registry Number: 79617-96-2

Descriptor UI: D020280

Alternative terms: Sertraline; Zoloft; Altruline; Parke Davis Brand of Sertraline Hydrochloride; Lustral; Pfizer Brand of Sertraline Hydrochloride; Roerig Brand of Sertraline Hydrochloride; Apo-Sertraline; Apo Sertraline; Apotex Brand of Sertraline Hydrochloride; Aremis; Esteve Brand of Sertraline Hydrochloride; Besitran; Sealdin; Lacer Brand of Sertraline Hydrochloride; Gladem; Boehringer Ingelheim Brand of Sertraline Hydrochloride; Novo-Sertraline; Novo Sertraline; Novopharm Brand of Sertraline Hydrochloride; ratio-Sertraline; ratio Sertraline; Ratiopharm Brand of Sertraline Hydrochloride; Rhoxal-sertraline; Rhoxal sertraline; Rhoxalpharma Brand of Sertraline Hydrochloride; Sertraline Hydrochloride; Hydrochloride, Sertraline; Sertraline Hydrochloride (1S-cis)-Isomer; Gen-Sertraline; Gen Sertraline; Genpharm Brand of Sertraline Hydrochloride;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Pharmacological Action: Antidepressive Agents; Serotonin Uptake Inhibitors;

Tree Number: D02.092.705.800; D02.455.426.559.847.638.845.800; D04.615.638.845.800;

History Note: 99; use SERTRALINE (NM) 1983-98